<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(1)</volume><submitter>Nishino J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>An alternative approach to investigate associations between genetic variants and disease is to examine deviations from the Hardy-Weinberg equilibrium (HWE) in genotype frequencies within a case population, instead of case-control association analysis. The HWE analysis requires disease cases and demonstrates a notable ability in mapping recessive variants. Allelic heterogeneity is a common phenomenon in diseases. While gene-based case-control association analysis successfully incorporates this heterogeneity, there are no such approaches for HWE analysis. Therefore, we proposed a gene-based HWE test (gene-HWT) by aggregating single-nucleotide polymorphism (SNP)-level HWE test statistics in a gene to address allelic heterogeneity.&lt;h4>Results&lt;/h4>This method used only genotype count data and publicly available linkage disequilibrium information and has a very low computational cost. Extensive simulations demonstrated that gene-HWT effectively controls the type I error at a low significance level and outperforms SNP-level HWE test in power when there are multiple causal variants within a gene. Using gene-HWT, we analyzed genotype count data from a genome-wide association study of six cancer types in Japanese individuals and suggest DGKE and ANO3 as potential germline factors in colorectal cancer. Furthermore, FSTL4 was suggested through a combined analysis across the six cancer types, with particularly notable associations observed in colorectal and prostate cancers.&lt;h4>Conclusions&lt;/h4>These findings indicate the potential of gene-HWT to elucidate the genetic basis of complex diseases, including cancer.</pubmed_abstract><journal>BMC genomics</journal><pagination>124</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11809088</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Gene-based Hardy-Weinberg equilibrium test using genotype count data: application to six types of cancers.</pubmed_title><pmcid>PMC11809088</pmcid><pubmed_authors>Nishino J</pubmed_authors><pubmed_authors>Kato M</pubmed_authors><pubmed_authors>Miya F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gene-based Hardy-Weinberg equilibrium test using genotype count data: application to six types of cancers.</name><description>&lt;h4>Background&lt;/h4>An alternative approach to investigate associations between genetic variants and disease is to examine deviations from the Hardy-Weinberg equilibrium (HWE) in genotype frequencies within a case population, instead of case-control association analysis. The HWE analysis requires disease cases and demonstrates a notable ability in mapping recessive variants. Allelic heterogeneity is a common phenomenon in diseases. While gene-based case-control association analysis successfully incorporates this heterogeneity, there are no such approaches for HWE analysis. Therefore, we proposed a gene-based HWE test (gene-HWT) by aggregating single-nucleotide polymorphism (SNP)-level HWE test statistics in a gene to address allelic heterogeneity.&lt;h4>Results&lt;/h4>This method used only genotype count data and publicly available linkage disequilibrium information and has a very low computational cost. Extensive simulations demonstrated that gene-HWT effectively controls the type I error at a low significance level and outperforms SNP-level HWE test in power when there are multiple causal variants within a gene. Using gene-HWT, we analyzed genotype count data from a genome-wide association study of six cancer types in Japanese individuals and suggest DGKE and ANO3 as potential germline factors in colorectal cancer. Furthermore, FSTL4 was suggested through a combined analysis across the six cancer types, with particularly notable associations observed in colorectal and prostate cancers.&lt;h4>Conclusions&lt;/h4>These findings indicate the potential of gene-HWT to elucidate the genetic basis of complex diseases, including cancer.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-04T02:27:31.673Z</modification><creation>2025-04-04T02:27:31.673Z</creation></dates><accession>S-EPMC11809088</accession><cross_references><pubmed>39930364</pubmed><doi>10.1186/s12864-025-11321-6</doi></cross_references></HashMap>